MedPro and Greiner Bio-One GmbH Announce Market Release of VACUETTE PSNS Tube-Touch

Lexington, KY – April 19, 2011 – MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, and its product partner Greiner Bio-One GmbH, today jointly announced the market release of the VACUETTE® PREMIUM Safety Needle System Tube-Touch.  The patented technology offers healthcare professionals the safety of a blood sample collection product with a truly passive needlestick prevention feature.  The Tube-Touch design has a safety mechanism that automatically activates through normal use, with no additional step by the user.  The product is being manufactured by Greiner Bio-One in their new state of the art facility in Upper Austria.  The first production units are now available for release to customers.

“The launch of the VACUETTE® PREMIUM Safety Needle System Tube-Touch product provides a safer alternative during blood collection to healthcare workers.  MedPro is pleased to provide this technology in partnership with our premier customer, Greiner Bio-One, as we continue to pursue our mission to protect healthcare workers through innovative passive sharps safety design,” stated Walter Weller, President of MedPro.  “The release of this product propels us towards fulfilling our strategic goal of bringing innovative safety design to the market.  We are pleased that one of the most respected manufacturing and distribution partners in the global pre-analytics marketplace will help make our technology accessible to the medical professional community.  The market release of the Tube-Touch system is the first of six products in various stages of development at MedPro that utilize our patented and truly passive product design and automatic safety functionality.  This significant corporate milestone also advances our continuing goal of increasing value for our shareholders.”

“Greiner Bio-One introduced the first plastic evacuated blood collection tube on the market to provide phlebotomist, nurse and laboratory professionals a new level of safety and product effectiveness that would help to eliminate the use of dangerous glass tubes,” stated Franz Konrad CEO of Greiner Bio-One.  “We continue to provide a high level of service to the medical professional community in the products we bring to customers.  We are thrilled to announce the addition of the VACUETTE® PREMIUM Safety Needle System Tube-Touch to the current Greiner Bio-One product line.”

The product will initially be sold in the US marketplace, with European CE Mark clearance expected during the second quarter of this year.  Interested parties should contact Greiner Bio-One offices in Monroe, North Carolina directly regarding product information and purchasing of this device.

About Greiner Bio-One GmbH

Greiner Bio-One GmbH is a world market leader in the field of biotechnology, diagnostics, pharmaceutical, medicine and In Vitro diagnostics. The company has three business units: Preanalytics, Bioscience and Mediscan and employs 1600 people. The product range of the Preanalytics Division is comprehensive, including products for blood collection, urine collection and specimen collection. Our specimen collection systems are sold in over 100 countries worldwide. The VACUETTE® blood collection system consists of blood collection tubes, multiple use drawing needles and various other blood collection accessories.

About MedPro Safety Products, Inc.

Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems.  The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners.  MedPro’s portfolio addresses multiple product categories within the medical delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets.  These products incorporate needlestick prevention features considered to be the most passive now available on the market as they require little or no clinician training compared to competitive products.  The total global market opportunity currently addressed by the Company’s products is estimated to be in excess of $6 billion.  For additional information, please refer to the ‘Investor Relations’ link on MedPro’s website (http://www.medprosafety.com).

Safe Harbor Statement

This release includes forward-looking statements based upon current expectations of the management of MedPro Safety Products, Inc. that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward- looking statements as a result of a number of factors, including our ability to identify and acquire medical safety device safety technologies with product development potential; our ability to successfully develop and bring products to market, including obtaining regulatory approvals; our ability to successfully increase sales of our products; our ability to obtain additional financing on satisfactory terms; our ability to attract and retain qualified employees; and governmental regulation associated with the medical safety products industry. Words such as "anticipate," "estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions are used to identify forward-looking statements. We refer you to the more detailed discussion of risks and uncertainties under "Risk Factors" in our Annual Report on Form 10-K and our other reports on file with the Securities and Exchange Commission.

Contact Information:

Investor Contact:

Doug Sherk/Jenifer Kirtland

EVC Group


Media Contact:

Steve DiMattia

EVC Group